Literature DB >> 10869870

Gamma-hydroxybutyric acid as a signaling molecule in brain.

M Maitre1, C Andriamampandry, V Kemmel, C Schmidt, Y Hodé, V Hechler, S Gobaille.   

Abstract

Gamma-hydroxybutyric acid was synthesized 35 years ago to obtain a GABAergic substance that penetrates the brain freely. Since then, gamma-hydroxybutyric acid has been used in human beings for its sedative and anesthetic properties when administered at high doses, and most of the studies on gamma-hydroxybutyric acid have focused on its pharmacological effects. However, gamma-hydroxybutyric acid is also an endogenous substance, which is synthesized and released in the brain by specific neuronal pathways, implicated in the control of the GABAergic, dopaminergic, and opioid systems. This control is mediated by specific gamma-hydroxybutyric acid receptors with a unique distribution in brain and a specific ontogenesis and pharmacology. Stimulation of these receptors induces specific cellular responses. Taken together, these results suggest that gamma-hydroxybutyric acid possesses most of the properties required of a neurotransmitter/neuromodulator in the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869870     DOI: 10.1016/s0741-8329(99)00092-0

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  8 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 2.  Style morphology and pollen tube pathway.

Authors:  M M Gotelli; E C Lattar; L M Zini; B G Galati
Journal:  Plant Reprod       Date:  2017-11-07       Impact factor: 3.767

3.  Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons.

Authors:  Amy K Goodwin; Wolfgang Froestl; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2005-03-01       Impact factor: 4.530

4.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

5.  Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine.

Authors:  Rajkumar J Sevak; Charles P France; Wouter Koek
Journal:  Eur J Pharmacol       Date:  2004-01-12       Impact factor: 4.432

Review 6.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

7.  Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study.

Authors:  Eleonora Napoli; Andrea Schneider; Jun Yi Wang; Aditi Trivedi; Nika Roa Carrillo; Flora Tassone; Michael Rogawski; Randi J Hagerman; Cecilia Giulivi
Journal:  Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.590

Review 8.  Metabolic Alterations in FMR1 Premutation Carriers.

Authors:  Yiqu Cao; Yun Peng; Ha Eun Kong; Emily G Allen; Peng Jin
Journal:  Front Mol Biosci       Date:  2020-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.